Legislative, Regulatory & Legal

The FDA has set a public hearing for May 31 on the safety of cannabis products.

The FDA announced a public hearing to advance access to insulin products, including biosimilar and interchangeable insulin products.

Ambrisentan tablets had a market value of $943 million in 2018.

As Walgreens tests locations without tobacco products, its parent company’s CEO Stefano Pessina said it would continue to sell cigarettes in most stores while highlighting smoking cessation options.

Sixty-two percent of Kentucky voters support an e-prescribing requirement as an opioid fraud and abuse prevention strategy.

Members of Congress are reporting to their constituents about discussions they had on DIR fees and opioids as part of NACDS RXImpact Day on Capitol Hill.

At a special meeting on Thursday, shareholder voted 78% in favor of the reverse split, the company said.

Teva is licensed to launch a generic version of Victoza as of Dec. 22, 2023 as the result of its settlement with Novo Nordisk, which manufactures the branded version of the drug.